New treatments and perspectives in metastatic TNBC with PARP Inhibitors.
Benjamin VERRET
Oncologist, Villejuif, France
Oncologist, Villejuif, France
New User? Click here to register
Text generated by AI based on an exclusive interview, revised and reviewed by
Luc Rotebenberg
Expert Opinions Dubai 2022
BCU General Secretary
Jean Jacques ZAMBROWSKI
Copyright © 2025 - BCU